These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24794)

  • 21. [Immunosuppressive agents in the therapy of rheumatic diseases].
    Lambić IS
    Med Glas; 1971; 25(7):269-73. PubMed ID: 5317046
    [No Abstract]   [Full Text] [Related]  

  • 22. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
    Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of inflammatory-rheumatic diseases with levamisol, an immunity modulating substance].
    Trabert U; Rosenthal M; Müller W
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1293-301. PubMed ID: 1087457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of selected laboratory findings in rheumatic diseases. 1: The first step in diagnosis].
    Apostoloff E; Hiepe F
    Z Arztl Fortbild (Jena); 1987; 81(9):407-9. PubMed ID: 2442893
    [No Abstract]   [Full Text] [Related]  

  • 25. The current clinical status of gold therapy in rheumatic diseases.
    Kaye RL
    J Rheumatol Suppl; 1982; 8():124-31. PubMed ID: 6982338
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiences in the management of rheumatoid diseases using different clofezone doses].
    Celik CM
    Z Rheumatol; 1976; 35(5-6):240-7. PubMed ID: 133565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The long term treatment of rheumatoid arthritis with D-penicillamine].
    Krüger HH
    Verh Dtsch Ges Rheumatol; 1969; 1():387-94. PubMed ID: 4997350
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents].
    Menninger H; Burkhardt H
    Fortschr Med; 1983 Apr; 101(14):639-45. PubMed ID: 6406333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Indomethacin in rheumatic diseases with special reference to ophthalmologic studies].
    Klein G; Fellner S; Fellner R
    Med Klin; 1972 Feb; 67(8):250-4. PubMed ID: 4555586
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
    Seidman EG; Furst DE
    J Rheumatol; 2002 Dec; 29(12):2484-7. PubMed ID: 12465139
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of various immunosuppressive agents in the treatment of rheumatoid polyarthritis. 41 personal cases].
    Vignon G; Bied JC
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):785-95. PubMed ID: 5152712
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gamma-glutamyltransferase and alkaline phosphatase in the serum and saliva of patients with hepatic tumors and hepatic cirrhosis].
    Jiménez-Alonso J; Jaimez L; Barrios L; Pérez-Jiménez F; García A; Bejarano R; Ogea JL; Jiménez-Pereperez JA
    Rev Esp Oncol; 1984; 31(2):315-9. PubMed ID: 6152769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antirheumatics. 40].
    Mayr E
    Pharm Prax; 1969 Dec; 12():265-7 concl. PubMed ID: 4909744
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunosuppressive therapy of glomerulotubular lesions in childhood].
    Hauschild G; Schöne D; Wässer S
    Z Urol Nephrol; 1970 May; 63(5):321-31. PubMed ID: 5513127
    [No Abstract]   [Full Text] [Related]  

  • 36. Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.
    Knipp S; Hildebrandt B; Richter J; Haas R; Germing U; Gattermann N
    Haematologica; 2005 May; 90(5):691-3. PubMed ID: 15921387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of various parameters on heparin utilization in short-term hemodialysis].
    Pristautz H; Katschnig H; Schenk H; Steinberger R; Pogglitsch H; Sailer S
    Med Welt; 1979 Dec; 30(49):1846-8. PubMed ID: 44539
    [No Abstract]   [Full Text] [Related]  

  • 38. [Positive and negative effects of cytostatic therapy in rheumatic patients].
    Krampac I
    Reumatizam; 1970; 17(2):51-4. PubMed ID: 5311483
    [No Abstract]   [Full Text] [Related]  

  • 39. [Polymorphism of chronic rheumatism in children. Notes on some clinical cases].
    Petrescu-Coman V; Pâtea P; Meilă P; Spătaru M; Bucur AI; Ioniţescu C; Parascan M; Nichifor C; Enache G
    Pediatria (Bucur); 1969; 18(2):99-110. PubMed ID: 5311133
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of rheumatoid disease with levamisole. Comparison of 2 dosage regimens].
    Corvetta A; Piani M; Bartocci C; Danieli G
    Minerva Med; 1982 May; 73(20):1375-82. PubMed ID: 6979013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.